The company said, ” We expect our EBITDA to grow in line with our medium-term outlook of between 4-8%. The outlook for FY25 reflects our current assessment of inflation and other macroeconomic conditions. Net pension interest expenses and accretion expenses are expected to be in the range of 190 to 220 million USD per quarter, depending on currency and interest rate fluctuations. We expect the average gross debt coupon in FY25 to be approximately 4%. We expect the normalized ETR in FY25 to be in the range of 26% to 28%. The ETR outlook does not consider the impact of potential future changes in legislation. We expect net capital expenditure of between 3.5 and 4.0 billion USD in FY25.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BUD:
- Is BUD a Buy, Before Earnings?
- Big alcohol looks to enter cannabis beverage market, Reuters reports
- Musk to launch new political party, Trump threatens BRICS tariff: Morning Buzz
- AB InBev Michelob Ultra sees growing sales while rivals’ sales slide, WSJ says
- AB InBev price target raised to EUR 72 from EUR 69 at Morgan Stanley